BIOCONNSEBiocon Limited· PharmaceuticalsMediumNeutral
Announced Wed, 6 May · 12:53 IST

The Exchange has sought clarification from Biocon Limited with respect to recent news item captioned Biocon s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report. The response from the Company is awaited.

Compliance

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.3%1-day move
₹370.00
prior close
₹380.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0+0.1+0.1+3.3+2.4+6.0+9.1+12.5+16.3+17.2+10.2+14.6
Up moveDown movePending
AI summary

The National Stock Exchange has asked Biocon Limited to clarify a media report claiming that Chairperson Kiran Mazumdar-Shaw has chosen her niece Claire Mazumdar as her successor. The company has not yet responded to the exchange query. This is a standard regulatory process where the exchange seeks company confirmation or clarification on market-moving news. No official statement has been made by Biocon regarding leadership transition plans.

Likely market impact

The stock may see increased volatility or investor attention as the market awaits the company's official response. Until Biocon confirms or denies the report, investors should treat the succession news as unconfirmed.